Skip to content

Evo sEEG System

by Neuroone Medical Technologies Corp.

510(k) K211367

Evo sEEG System is a medical device (FDA Class II; FDA product code GZL, Electrode, Depth) made by Neuroone Medical Technologies Corp., cleared under FDA 510(k) K211367 on 1 Sep 2021, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK211367 Date1 Sep 2021ClearedStatusActive

Official records

From the FDA record

Received by the FDA
4 May 2021
FDA decision
1 Sep 2021 (Substantially Equivalent)
FDA review time
120 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K211367 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
GZL
Device class
Class II
Regulation
21 CFR Part 882.1330
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code GZL (Electrode, Depth).

Other devices from Neuroone Medical Technologies Corp.

See all devices from Neuroone Medical Technologies Corp. →